论文部分内容阅读
摘要目的针对管电压前瞻性制定主动脉CTA病人的个体化低对比剂(CM)用量的方案。方法研究通过本单位伦理委员会和当地伦理委员会批准。全部病人知情同意。CTA
Abstract Objective To prospectively develop an individualized low contrast agent (CM) dosage regimen for patients with aortic CTA. Methodological studies are approved by the ethics committee and the local ethics committee. All patients informed consent. CTA